Just In
- 5 hrs ago Heeramandi Screening: Alia Bhatt, Ananya Panday, Rashmika Mandanna And Others Serve Finest Ethnic Style!
- 6 hrs ago From Alia Bhatt To Kriti Sanon, Korean Beauty Products That Bollywood Divas Swear By
- 9 hrs ago Exclusive: On World Malaria Day 2024, Dr Shares Danger Signs Parents Must Watch Out For In Child With Malaria
- 9 hrs ago Exclusive: Expert Debunks 5 Common Misconceptions About Expectant Mothers That You Need To Steer Clear From
Don't Miss
- Movies Kalki 2898 AD: Facts About Ashwatthama To Know Before Watching Prabhas-Amitabh Bachchan's Film
- News Who Is Lisa Pisano, New Jersey Woman Gets Pig Kidney Transplant And Heart Pump?
- Sports Pakistan vs New Zealand 4th T20 Live Score, Latest Updates From Lahore: Toss at 7:00 PM PST
- Finance Tech Mahindra Q4 Results: Cons PAT Declines 41% YoY To Rs 661 Crore; Exits FY24 In Red
- Automobiles Royal Enfield Unveils Revolutionary Rentals & Tours Service: Check Out All Details Here
- Technology Elon Musk’s X Is Launching a TV App Similar to YouTube for Watching Videos
- Education AICTE introduces career portal for 3 million students, offering fully-sponsored trip to Silicon Valley
- Travel Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
Government Allows Serum Institute To Export 50 Lakh Covishield Doses Under Covax To 4 Nations
The Union government has allowed the Serum Institute of India to export 50 lakh doses of COVID-19 vaccine Covishield under the UN-backed COVAX global vaccine programme to Nepal, Tajikistan and Mozambique, official sources said on Sunday.
In addition to these three countries, the SII will also export Covishield to Bangladesh under COVAX, they said.
The SII will commence Covid vaccine export under the COVAX programme from November 23 and Nepal will receive the first lot of Covishield on November 24.
The government, earlier in October, had permitted the SII to export 10 lakh Covishield doses each to Nepal, Myanmar and Bangladesh under the 'Vaccine Maitri' programme.
In a recent communication to the Union Health Ministry, Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of India (SII) is learnt to have informed that the Pune-based firm has manufactured stock of 24,89,15,000 doses of Covishield and that the stock is increasing day by day.
- wellnessCervical Cancer Vaccine: All You Need To Know About India's Self-Developed HPV Vaccine
- wellnessDCGI Approves India's First qHPV Vaccine Against Cervical Cancer
- kidsSerum Institute Seeks Covovax's Inclusion In Covid Vaccination Drive For 12 Years And Over
- wellnessDCGI Grants Emergency Use Authorisation To Covovax For 12-17 Years Age Group; Younger Age Groups To Follow
- healthReduce Gap Between 2nd Dose And Precaution Dose Of Covishield, Urges Serum Institute To Health Ministry
- healthSerum Institute CEO Hails WHO's Approval Of Covovax For Emergency Use
- healthSerum Institute Urges Govt To Fast-Track Movement Of Increasing Covishield Stock
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- wellnessCorbevax Will Be Allowed As A Booster For Those Fully Vaccinated With Covishield Or Covaxin
- wellnessBooster Dose Of COVID Vaccine Needed To Fight Against Omicron: Study
- wellnessCovishield Dose Gap Reduced To 8-16 Weeks From 12-16
- healthEach Dose Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Getting Regular Market Approval